Samuel D. Isaly just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though Samuel D. Isaly claims to own 3,298,516 shares. This represents 23.76% of Nivalis Therapeutics, Inc..

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Nivalis Therapeutics, Inc. makes a similar move, sign up!

Auto Refresh